TGFB1 and diabetes mellitus: To investigate the possible reasons for the late onset of diabetes-induced pathological effects in the lung, we hypothesized that SMAD7, a negative regulator of TGF-β1 activation, protected the lung during the early stages of diabetes and that the levels of SMAD7 decrease with an increasing duration of diabetes.